Crispr Therapeutics AG vs Carparts.Com Inc — how do they compare? Crispr Therapeutics AG trades at $54.31 (market cap $5.23B), while Carparts.Com Inc trades at $6.41 (market cap $51.67M). The key difference: Crispr Therapeutics AG is far larger — about 101.2× Carparts.Com Inc's market cap. Which is the better fit depends on your goals.
| CRSP | PRTS | |
|---|---|---|
Market Cap | $5.23B | $51.67M |
Sector | Health | Consumer Cyclical |
52-Week High | $76.78 | $11.40 |
52-Week Low | $44.34 | $3.88 |
Enterprise Value | $3.65B | $66.64M |
Trailing returns across standard periods
Latest headlines on both assets
CRISPR Therapeutics is a gene editing company focused on the development of CRISPR/Cas9-based therapeutics. CRISPR/Cas9 stands for Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9), which is a revolutionary technology for precisely altering specific sequences of genomic DNA. The company is focused on using this technology to treat genetically defined diseases. CRISPR's most advanced pipeline candidate, CTX001, is in collaboration with Vertex Pharmaceuticals and targets sickle cell disease and transfusion-dependent beta-thalassemia, which have high unmet medical needs. The company is progressing additional gene editing programs for immuno-oncology, as well as a stem cell-derived therapy for the treatment of Type 1 diabetes.
Read more on CRSP →CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
Read more on PRTS →